“…In the cross-sectional CDACD study, 114 adolescents aged 12–18 were prospectively enrolled between April 2017 and June 2019, as recently published [2] . The study population included patients with metabolic, inflammatory, and hemodynamic disorders: cystic fibrosis (CF, n = 24), corrected coarctation of the aorta (CoA, n = 25), rheumatoid factor negative polyarticular or extended oligoarticular juvenile idiopathic arthritis (JIA, n = 20), obesity (n = 20), and as a control group healthy adolescents with a corrected atrial septal defect (ASD), who showed normal cardiac dimensions and functions during follow-up (n = 25).…”